Código QR

Real-world early- to midterm outcomes of aortic valve replacement using novel tissue technology bioprosthesis at a high-volume centerCentral MessagePerspective

Objective: The INSPIRIS-RESILIA aortic valve (Edwards Lifesciences) uses a novel tissue-fixation technology to enhance the bioprosthesis's longevity. We sought to report midterm INSPIRIS-RESILIA aortic bioprosthesis performance in a large contemporary cohort at a single institution. Methods: Between...

Descripción completa

Guardado en:
Autores principales: Emily Vianna, MD, Patrick R. Vargo, MD, L. Leonardo Rodriguez, MD, Salvatore Poddi, MD, Kelsey Curran, MPH, Jeevanantham Rajeswaran, PhD, Shinya Unai, MD, Eric E. Roselli, MD, Lars G. Svensson, MD, PhD, Haytham Elgharably, MD, PhD
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2026-04-01
Colección:JTCVS Open
Materias:
INSPIRIS-RESILIA
AVR
SVD
bioprosthesis
Acceso en línea:http://www.sciencedirect.com/science/article/pii/S2666273626000409
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares